Publications by authors named "Matthew D Breyer"

Claim this Profile
A
AKR1A1 and Kidney Disease: Promise and Perils of the Multiverse.
Matthew D Breyer

Diabetes· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine.
Anna Reznichenko, Viji Nair, Sean Eddy, Damian Fermin, Mark Tomilo, Matthew D Breyer

Kidney Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I 2 Receptor.
Jing Li, Yi Guan, Yunyu Xu, Yingxue Cao, Qionghong Xie, Matthew D Breyer

J Am Soc Nephrol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tackling AKI.
Rajashree Rana, Matthew D Breyer

J Am Soc Nephrol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies.
Haojia Wu, Romer Gonzalez Villalobos, Xiang Yao, Dermot Reilly, Tao Chen, Matthew D Breyer

Cell Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase-2 contributes to diabetic nephropathy through glomerular EP4 receptor.
Yi Guan, Linda Davis, Matthew D Breyer, Chuan-Ming Hao

Prostaglandins Other Lipid Mediat· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43:2760-2767.
Katsuhito Ihara, Jan Skupien, Hiroki Kobayashi, Zaipul I Md Dom, Jonathan M Wilson, Matthew D Breyer

Diabetes Care· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.
Katsuhito Ihara, Jan Skupien, Hiroki Kobayashi, Zaipul I Md Dom, Jonathan M Wilson, Matthew D Breyer

Diabetes Care· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Genomics to Drive Kidney Disease Drug Discovery and Development.
Dermot F Reilly, Matthew D Breyer

Clin J Am Soc Nephrol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease.
Min Zhang, Manakan B Srichai, Min Zhao, Jian Chen, Linda S Davis, Matthew D Breyer

Int J Med Sci· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting VE-PTP phosphatase protects the kidney from diabetic injury.
Isabel A Carota, Yael Kenig-Kozlovsky, Tuncer Onay, Rizaldy Scott, Benjamin R Thomson, Matthew D Breyer

J Exp Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological and Transcriptome Changes in the ReninAAV db/ db uNx Model of Advanced Diabetic Kidney Disease Exhibit Features of Human Disease.
Shannon M Harlan, Kathleen M Heinz-Taheny, Jessica M Overstreet, Matthew D Breyer, Raymond C Harris

Toxicol Pathol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Natalia Nowak, Jan Skupien, Adam M Smiles, Masayuki Yamanouchi, Monika A Niewczas, Matthew D Breyer

Kidney Int· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
Shannon M Harlan, Kathleen M Heinz-Taheny, John M Sullivan, Tao Wei, Hana E Baker, Matthew D Breyer

J Am Soc Nephrol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel avenues for drug discovery in diabetic kidney disease.
Matthew D Breyer, Matthias Kretzler

Expert Opin Drug Discov· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
Masayuki Yamanouchi, Jan Skupien, Monika A Niewczas, Adam M Smiles, Alessandro Doria, Matthew D Breyer

Kidney Int· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of TGF-alpha in the progression of diabetic kidney disease.
Josef G Heuer, Shannon M Harlan, Derek D Yang, Dianna L Jaqua, Jeffrey S Boyles, Matthew D Breyer

Am J Physiol Renal Physiol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Treatments for Chronic Kidney Disease in the 21st Century.
Matthew D Breyer, Katalin Susztak

Semin Nephrol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The next generation of therapeutics for chronic kidney disease.
Matthew D Breyer, Katalin Susztak

Nat Rev Drug Discov· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.
Peter G Linde, Patrick Archdeacon, Matthew D Breyer, Tod Ibrahim, Jula K Inrig

J Am Soc Nephrol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice.
Michael Fritz, Anna M Klawonn, Anna Nilsson, Anand Kumar Singh, Joanna Zajdel, Matthew D Breyer

J Clin Invest· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From bench to patient: model systems in drug discovery.
Matthew D Breyer, A Thomas Look, Alessandra Cifra

Dis Model Mech· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral transduction of renin rapidly establishes persistent hypertension in diverse murine strains.
Shannon M Harlan, Robert A Ostroski, Tamer Coskun, Loudon D Yantis, Matthew D Breyer

Am J Physiol Regul Integr Comp Physiol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.
Rajiv Agarwal, Kevin L Duffin, Dennis A Laska, James R Voelker, Matthew D Breyer

Nephrol Dial Transplant· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulin.
Catherine B Beidler, Ramona J Petrovan, Elaine M Conner, Jeffrey S Boyles, Derek D Yang, Matthew D Breyer

J Pharmacol Exp Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis